Michelle Renee Griffin - May 18, 2021 Form 4 Insider Report for Adaptive Biotechnologies Corp (ADPT)

Role
Director
Signature
/s/ Michelle Griffin by Eric Billings, attorney-in-fact
Stock symbol
ADPT
Transactions as of
May 18, 2021
Transactions value $
-$68,000
Form type
4
Date filed
5/19/2021, 08:00 PM
Next filing
Jun 7, 2021

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ADPT Common Stock Options Exercise $19.5K +2.5K +166.22% $7.80 4K May 18, 2021 Direct F1
transaction ADPT Common Stock Sale -$87.5K -2.5K -62.44% $35.00 1.5K May 18, 2021 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ADPT Stock Option (Right to Buy) Options Exercise $0 -2.5K -3.18% $0.00 76K May 18, 2021 Common Stock 2.5K $7.80 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 14, 2020.
F2 The options vested with respect to 1/4 of such shares on March 28, 2020, with 1/48 of such shares vesting thereafter at the end of each full month of continuous service until fully vested.